Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Kristina M. Deligiannidis |
Documentos disponibles escritos por este autor (4)
Refinar búsquedaAntidepressant augmentation using the N-methyl-D-aspartate antagonist memantine / Eric G. Smith en The Journal of Clinical Psychiatry, Año 2013 - Vol.74 - No.10 (Octubre)
Título : Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine : a randomized, double-blind, placebo-controlled trial Tipo de documento: texto impreso Autores: Eric G. Smith, Autor ; Kristina M. Deligiannidis, Autor ; Christine M. Ulbricht, Autor Fecha de publicación: 2022 Artículo en la página: pp. 966-973 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Depresión - terapia con medicamentos, Trastorno depresivo mayor, Terapia farmacológica, Agonistas de aminoácidos excitadores, Memantina. Resumen: Intravenous N-methyl-d-aspartate (NMDA) antagonists have shown promising results in rapidly ameliorating depression symptoms, but placebo-controlled trials of oral NMDA antagonists as monotherapy have not observed efficacy. Link: ./index.php?lvl=notice_display&id=27885
in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.10 (Octubre) . - pp. 966-973[artículo] Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine : a randomized, double-blind, placebo-controlled trial [texto impreso] / Eric G. Smith, Autor ; Kristina M. Deligiannidis, Autor ; Christine M. Ulbricht, Autor . - 2022 . - pp. 966-973.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.10 (Octubre) . - pp. 966-973
Palabras clave: Antidepresivos, Depresión - terapia con medicamentos, Trastorno depresivo mayor, Terapia farmacológica, Agonistas de aminoácidos excitadores, Memantina. Resumen: Intravenous N-methyl-d-aspartate (NMDA) antagonists have shown promising results in rapidly ameliorating depression symptoms, but placebo-controlled trials of oral NMDA antagonists as monotherapy have not observed efficacy. Link: ./index.php?lvl=notice_display&id=27885
Título : Complementary and alternative medicine for the treatment of depressive disorders in women Tipo de documento: texto impreso Autores: Kristina M. Deligiannidis, Autor ; Marlene P. Freeman, Autor Fecha de publicación: 2020 Artículo en la página: p. 441-463 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Tratamiento complementario / alternativo, S-adenosilmetionina, Ácidos grasos omega-3, Hierba de San Juan, Acupuntura, Depresión, Mujeres Resumen: Complementary and alternative medicine (CAM) therapies are commonly practiced in the United States and are used more frequently among women than men. This article reviews several CAM treatments for depressive disorders in women, with a focus on major depressive disorder across the reproductive life cycle. Link: ./index.php?lvl=notice_display&id=24425
in Psychiatric Clinics of North America > Año 2010 - Vol.33 No. 2 (Junio) . - p. 441-463[artículo] Complementary and alternative medicine for the treatment of depressive disorders in women [texto impreso] / Kristina M. Deligiannidis, Autor ; Marlene P. Freeman, Autor . - 2020 . - p. 441-463.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2010 - Vol.33 No. 2 (Junio) . - p. 441-463
Palabras clave: Tratamiento complementario / alternativo, S-adenosilmetionina, Ácidos grasos omega-3, Hierba de San Juan, Acupuntura, Depresión, Mujeres Resumen: Complementary and alternative medicine (CAM) therapies are commonly practiced in the United States and are used more frequently among women than men. This article reviews several CAM treatments for depressive disorders in women, with a focus on major depressive disorder across the reproductive life cycle. Link: ./index.php?lvl=notice_display&id=24425
Título : A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD) : gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures Tipo de documento: texto impreso Autores: Kristina M. Deligiannidis, Autor ; Anthony J. Rothschild, Autor ; Bruce A. Barton, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1003-1009 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Índice de masa corporal, Peso corporal, Trastorno depresivo mayor, Terapia farmacológica, Alucinaciones, Sertralina. Resumen: Gender differences exist in psychiatric disorders; however, gender has not been well studied in psychotic depression. This analysis of the largest clinical trial in psychotic depression examined the effects of age and gender on clinical characteristics and predictors of treatment outcome and treatment-associated changes in body mass index (BMI) and metabolic measures. Link: ./index.php?lvl=notice_display&id=27890
in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.10 (Octubre) . - pp. 1003-1009[artículo] A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD) : gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures [texto impreso] / Kristina M. Deligiannidis, Autor ; Anthony J. Rothschild, Autor ; Bruce A. Barton, Autor . - 2022 . - pp. 1003-1009.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.10 (Octubre) . - pp. 1003-1009
Palabras clave: Antipsicóticos, Benzodiazepinas, Índice de masa corporal, Peso corporal, Trastorno depresivo mayor, Terapia farmacológica, Alucinaciones, Sertralina. Resumen: Gender differences exist in psychiatric disorders; however, gender has not been well studied in psychotic depression. This analysis of the largest clinical trial in psychotic depression examined the effects of age and gender on clinical characteristics and predictors of treatment outcome and treatment-associated changes in body mass index (BMI) and metabolic measures. Link: ./index.php?lvl=notice_display&id=27890
Título : Zuranolone for the Treatment of Postpartum Depression Tipo de documento: texto impreso Autores: Kristina M. Deligiannidis, Autor ; Samantha E. Meltzer-Brody, Autor ; Bassem Maximos, Autor Fecha de publicación: 2024 Artículo en la página: pp. 668-675 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos del estado de ánimo-posparto, Farmacoterapia Resumen: Postpartum depression (PPD) is a common perinatal complication with adverse maternal and infant outcomes. This study investigated the efficacy and safety of zuranolone, a positive allosteric modulator of synaptic and extrasynaptic GABAA receptors and neuroactive steroid, as an oral, once-daily, 14-day treatment course for patients with severe PPD. Link: ./index.php?lvl=notice_display&id=31285
in The American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 9 (Septiembre) . - pp. 668-675[artículo] Zuranolone for the Treatment of Postpartum Depression [texto impreso] / Kristina M. Deligiannidis, Autor ; Samantha E. Meltzer-Brody, Autor ; Bassem Maximos, Autor . - 2024 . - pp. 668-675.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 9 (Septiembre) . - pp. 668-675
Palabras clave: Trastornos del estado de ánimo-posparto, Farmacoterapia Resumen: Postpartum depression (PPD) is a common perinatal complication with adverse maternal and infant outcomes. This study investigated the efficacy and safety of zuranolone, a positive allosteric modulator of synaptic and extrasynaptic GABAA receptors and neuroactive steroid, as an oral, once-daily, 14-day treatment course for patients with severe PPD. Link: ./index.php?lvl=notice_display&id=31285
